27.01.2015 Views

REP11/PR JOINT FAO/WHO FOOD STANDARDS PROGRAMME ...

REP11/PR JOINT FAO/WHO FOOD STANDARDS PROGRAMME ...

REP11/PR JOINT FAO/WHO FOOD STANDARDS PROGRAMME ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>REP11</strong>/<strong>PR</strong> 15<br />

ESTABLISHMENT OF THE <strong>PR</strong>IORITY LISTS OF PESTICIDES (Agenda Item 12a) 19<br />

138. The Delegation of Australia, as Chair of the in-session Working Group on Priorities introduced the report of the working group.<br />

The Chair mentioned the addition of new information on registration status, expected residues and residue trials available in order to<br />

help setting priorities. He also mentioned new appendixes to the schedule, mentioning compounds which are no longer supported by<br />

industry (Table 5) and commodities which are no longer supported by industry (Table 6). These two appendices will increase the<br />

transparency and will allow member states to be prepared to support compounds and commodities no longer supported by industry.<br />

Periodic Re-evaluation<br />

139. Procymidone (136) and Vinclozolin (159) are no longer supported by industry and member countries. Therefore, the<br />

Committee decided that all CXLs for these 2 compounds should be revoked.<br />

140. After some discussions and adjustments, the Committee agreed on the Priority List for 2012 provided as Appendix XI.<br />

Scheduling of chemicals<br />

141. The Committee was informed that 12 chemicals had been nominated for inclusion on the schedule for new compounds and<br />

periodic re-evaluation for 2012. The Chair listed the seven new chemical evaluations (ametoctradin, chlorfenapyr, dinotefuran,<br />

fluxapyroxad, MCPA, picoxystrobin, sedaxane), and the five chemicals listed for periodic re-evaluation (bentazone, cycloxydim,<br />

dichlorvos, fenvalerate, glufosinate-ammonium). The delegations of Thailand and the United States of America confirmed their<br />

support to the re-evaluation of fenvalerate which is not longer supported by the primary manufacturer.<br />

142. The Committee nominated 21 chemicals for follow-up evaluations namely fenbuconazole for consideration of the<br />

establishment of an ARfD and 20 substances for MRLs in additional commodities (buprofezin, captan, carbofuran, chlorothalonil,<br />

chlorpyrifos-methyl, cyfluthrin, cyproconazole, cyromazine, 2,4-D, dithiocarbamates-mancozeb, fludioxynil, flupyram, imidacloprid,<br />

methoxyfenozide, oxamyl, phorate, spinetoram, thiacloprid, thiamethoxate and trifloxystrobin).<br />

143. The Committee was informed that this number of compounds exceed the possibilities of the JM<strong>PR</strong> regarding the<br />

establishment of MRLs. It was therefore proposed by Croplife to postpone the periodic re-evaluation of residue limits for bentazone<br />

until 2013 but to keep this compound for toxicological re-evaluation in 2012. The Committee was advised that with these<br />

adjustments, the 2012 schedule had reached its quota and technically could not accept any further nominations.<br />

144. The Committee noted the chemicals listed for new evaluation and follow-up evaluation for the years 2013 to 2018 and that for<br />

2013, 12 new compounds are listed for evaluation and 13 compounds are listed for periodic re-evaluation. This is clearly exceeding<br />

the capacities of the JM<strong>PR</strong>. Moreover, the Committee also noted that more than 40 substances are already on the list for periodic reevaluation<br />

following the rule of 15 years. The Committee agreed to give the mandate to the Working Group on Priorities to propose a<br />

list of 2 to 3 chemicals every year, from the full list of substances candidate for periodic re-evaluation, based on their potential higher<br />

concern regarding public health.<br />

145. The Chair indicated that the work of the EWG for 2012 would commence in August with the broadcast email to all member<br />

countries and observers. In that correspondence, the Chair will highlight chemicals for which there is no manufacturer support and<br />

chemicals for which commodity listings are required. The Chair will also propose a re-ordering of the list of chemicals candidate for<br />

periodic re-evaluation based of the potential health concerns. The Committee agreed to reconvene the electronic working group<br />

chaired by Australia for 2012.<br />

CONSIDERATION OF THE STATUS OF CODEX MRLs for LINDANE (Agenda Item 12b) 20<br />

146. The Delegation of Australia, as Chair of the on in-session Working Group on Priorities introduced this item vis-à-vis the<br />

relation between the status of Codex MRLs for lindane and the Priority List as per the eligibility of this compound for re-evaluation in<br />

the future.<br />

147. The Committee noted that lindane is currently listed in Annex A of the Stockholm Convention by which Parties must take<br />

measures to eliminate the production and use of the chemicals listed under this Annex. The Committee considered the possible<br />

replacement of the existing lindane MRLs with EMRLs based on the different options provided for in the discussion paper.<br />

19 CX/<strong>PR</strong> 11/14/13 & CX/<strong>PR</strong> 11/14/13-Add.1. CX/<strong>PR</strong> 11/14/13-Add.2 (comments from Brazil, Canada and Uruguay). Additional comments from Kenya (CRD 5);<br />

EU (CRD 14); Mali (CRD 21); Australia (CRD 26); and the Democratic People’s Republic of Korea (CRD 27).<br />

20 CX/<strong>PR</strong> 11/43/14. Comments from Kenya (CRD 5) and Croplife (CRD 7).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!